✦ LIBER ✦

Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening

✍ Scribed by Lena Bezman; Ann B. Moser; Gerald V. Raymond; Piero Rinaldo; Paul A. Watkins; Kirby D. Smith; Nancy E. Kass; Hugo W. Moser

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 371 KB
Volume: 49
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.101

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Utilizing the plasma very long chain fatty acid assay, supplemented by mutation analysis and immunofluorescence assay, we determined the number of X‐linked adrenoleukodystrophy (X‐ALD) hemizygotes from the United States identified each year in the two laboratories that perform most of the assays in this country: the Kennedy Krieger Institute between 1981 and 1998 and the Mayo Clinic Rochester from 1996 to 1998. The minimum frequency of hemizygotes identified in the United States is estimated to be 1:42,000 and that of hemizygotes plus heterozygotes 1:16,800. Our studies involved 616 pedigrees with a total of 12,787 identified at‐risk members. Diagnostic assays were performed in 4,169 at‐risk persons (33%) and included members of the extended family. Only 5% of male probands and 1.7% of X‐ALD hemizygotes were found to have new mutations. The extended family testing led to the identification of 594 hemizygotes and 1,270 heterozygotes. Two hundred fifty of the newly identified hemizygotes were asymptomatic and represent the group in which therapy has the greatest chance of success. Identification of heterozygotes provides the opportunity for disease prevention through genetic counseling. Diagnostic tests should be offered to all at‐risk relatives of X‐ALD patients and should include members of the extended family. Ann Neurol 2001;49:512–517

📜 SIMILAR VOLUMES

Extended investigation of tau and mutati

Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 family

✍ Froelich Fabre, Susanne ;Axelman, Pia ;Almkvist, �sa ;Basun, Hans ;Lannfelt, Lar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract Frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP‐17) is an autosomal dominant condition clinically characterized by behavioral, cognitive and motor disturbances. It was recently discovered that the majority of the FTDP‐17 families carry missense or 5′ splice mutati

Confirmation of prenatal diagnosis resul

Confirmation of prenatal diagnosis results of X-linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene

✍ Stephan M. Tanner; Jocelyn Laporte; Christophe Guiraud-Chaumeil; Sabina Liechti- 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 2 views

X-linked recessive myotubular myopathy (XLMTM; MTM1) is a severe neonatal disorder often causing perinatal death of the affected males. The responsible gene, designated MTM1, was localized to proximal Xq28 and recently isolated. The characterization of MTM1 allowed us to screen for causing mutations